CASPIAN THERAPEUTICS

What this means for you

Not registered yet, but its 11 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98219075

Mark type

Stylized text

Filed

11 Oct 2023

Published for opposition

17 Dec 2024

Attorney of record

Anna E. Raimer

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
• Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of treatment of oncological diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of oncological diseases, disorders, and conditions; consulting services in the field of research and development of treatments of oncological diseases, disorders, and conditions; cancer treatment research and development

Owner

• Kura Oncology, Inc., San Diego, CA, US
• Kura Oncology, Inc., San Diego, CA, US

Prosecution history

• 01 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 31 Jan 2026 — SOU EXTENSION 2 GRANTED
• 31 Jan 2026 — SOU EXTENSION 2 FILED
• 31 Jan 2026 — SOU TEAS EXTENSION RECEIVED
• 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 29 May 2025 — SOU EXTENSION 1 GRANTED
• 29 May 2025 — SOU EXTENSION 1 FILED
• 29 May 2025 — SOU TEAS EXTENSION RECEIVED
• 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 17 Dec 2024 — PUBLISHED FOR OPPOSITION
• 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 17 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 03 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 03 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE